Our study revealed that atorvastatin has decreasing effect on U levels, whereas increasing effect on U levels. We think it cannot certainly be deduced that atorvastatin could be beneficial on overall urinary metabolic risk factors. Contrarily, atorvastatin may lead to an increased risk of calcium stones, but when considering its U decreasing effect, it may help in reducing the uric acid stone recurrence.